Zotefoams PLC Replacement Notice Transactions Of Directors/PDMRs (2825X)

TIDMZTF

RNS Number : 2825X

Zotefoams PLC

24 April 2023

The following amendments have been made to the ' Notification Of Transactions Of Directors/PDMRs' announcement released on 24 April 2023 at 16:42 under RNS Number: 2739X

An incorrect reference to the Long-Term Incentive Plan has been removed. The date of 24 April 2023, in the second paragraph, has been replaced with 20 April 2023. All other details remain unchanged.

The full amended text is shown below.

Zotefoams plc

(the 'Company')

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

24 April 2023 - On 20 April 2023, the Company received notice from its Employee Benefit Trust of the exercise and partial sale for tax of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's 2017 Deferred Bonus Share Plan ('DBSP') at a sale price of GBP3.82 as follows:

 
                   Number       Number        Number        Number        Number      Balance 
                  of shares    of shares     of shares     of shares     of shares     of shares 
                  exercised      sold       anticipated      sold       anticipated    anticipated 
                                             still to       for tax      still to      to be retained 
                                              be sold                     be sold      and transferred 
                                                                          for tax      to Director 
 D B Stirling      12,307       6,057         6,250           -             -                        - 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 G C McGrath       7,741          -             -           1,828         1,810                  4,103 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 
                            PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES 
                   Number       Number        Number        Number        Number      Balance 
                  of shares    of shares     of shares     of shares     of shares     of shares 
                  exercised      sold       anticipated      sold       anticipated    to be retained 
                                             still to       for tax      still to      and transferred 
                                              be sold                     be sold      to PDMR 
                                                                          for tax 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 K D Hewson        5,613        2,762         2,851           -             -                - 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 J P Bridges       3,773        1,857         1,916           -             -                - 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 H D Morgan        6,769                                    1,585         1,596            3,588 
                -----------  -----------  -------------  -----------  -------------  ----------------- 
 B Sala            3,860                                     911           903             2,046 
                -----------  -----------  -------------  -----------  -------------  -----------------

The shares in the "Number of shares anticipated still to be sold for tax" column are those that the Company has been notified are still to be sold for the purpose of satisfying the tax liability generated by the exercise of the options, but which have not been sold as at 20 April 2023. These shares have not been transferred into the name of the Director.

Awards granted under the DBSP usually vest three years from grant, subject to satisfaction of service conditions. The awards were increased to reflect the dividends paid during the restricted period.

The Notification of Dealing Form for each Director/PDMR can be found below.

This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM